LRRK2 and Parkinson disease: With respect to Parkinson’s disease, dual roles of Rabs 29 and 32 as LRRK2 activators and Parkinson’s disease risk genes highlights the broader importance of defining how and when such proteins are engaged in LRRK2 regulation (Gustavsson et al., 2024; Hop et al., 2024).